Satellos Bioscience Inc. (MSLE) Financials

MSLE Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 31.9 million 4.1 million
Sept. 30, 2025 37.5 million 3.5 million
June 30, 2025 41.1 million 2.8 million
March 31, 2025 44.4 million 2.7 million

MSLE Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -7.3 million 985000
Sept. 30, 2025 -4.1 million 774000
June 30, 2025 -4.8 million 834000
March 31, 2025 -7.4 million 642000

MSLE Net Income

No data available :(

MSLE Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 - - -
Sept. 30, 2025 34.6 million - -
June 30, 2025 38.2 million - -
March 31, 2025 41.2 million - -

MSLE Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 15.5 million
Sept. 30, 2025 13.9 million
June 30, 2025 14.3 million
March 31, 2025 13.8 million

MSLE Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 5.5 million 2.0 million -
Sept. 30, 2025 3000 4.0 million 1.9 million -
June 30, 2025 3000 4.4 million 1.7 million -
March 31, 2025 - 4.5 million 1.8 million -

MSLE Cost of Revenue

No data available :(

MSLE

Price: $9.78

52 week price:
4.64
13.40

Earnings Per Share: -1.70 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical - Pharmaceuticals

Market Capitalization: 10.7 million

Links: